We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pharmacy benefit manager (PBM) reimbursements to pharmacies have failed to keep up with price increases for generic drugs, according to an analysis by 3 Axis Advisors, a consulting group that tracks drug supply-chain inefficiencies and pricing. Read More
In a letter to the FDA last week, 35 federal lawmakers recommend the agency consider approving human “challenge” trials for COVID-19, which would infect healthy volunteers with the deadly virus to test efficacy of a vaccine. But the FDA and some researchers have expressed concern over the ethics involved. Read More
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is relaxing some GMP requirements to help manufacturers overcome challenges during the COVID-19 pandemic. Read More
Immunomedic’s Trodelvy (sacituzumab govitecan-hziy) earned accelerated approval for treatment of adults with triple-negative breast cancer that has metastasized. Read More
In an emergency final guidance released yesterday, the FDA agency said it is temporarily relaxing its regulations for repackaging and combining units of propofol during the COVID-19 pandemic. Read More